TRUOZA
Live / Allowed — Notice of allowance issued (as of 30 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99105594
- Mark type
- Stylized text
- Filed
- 26 Mar 2025
- Published for opposition
- 10 Jun 2025
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders
Owner
- TEVA PHARMACEUTICALS USA, INC., Parsippany, NJ, US
- TEVA PHARMACEUTICALS USA, INC., Building A, NJ, US
Prosecution history
- 21 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Jan 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 May 2025 — ASSIGNED TO EXAMINER
- 26 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Mar 2025 — NEW APPLICATION ENTERED